Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Dr Maycock indicated that he expected one third of the plasma from England would be processed at Liberton.

Published on: 30 August, 2024

At the end of December 1969 it was known to be unlikely that the Protein Fractionation Centre would begin production before the second half of 1973.

Published on: 30 August, 2024

Treasury approval was given to a final cost limit of £1,728,079 for the work on the Protein Fractionation Centre.

Published on: 11 October, 2024

The Expert Group on the Treatment of Haemophilia emphasised the importance of taking a UK view of provision for haemophilia therapy.

Published on: 30 August, 2024

At the minimum level of working, it was expected that 1,000 litres of plasma would come from Scotland each week, and the remaining 500 litres would come from England. John Watt questioned how this would work since there was no available plasma in England available at that time.

Published on: 30 August, 2024

In his evidence, Dr Foster explained that John Watt considered a fractionation centre should support a population of at least 15 million to be economically viable meaning that the population of Scotland was too small, in his opinion, for the Protein Fractionation Centre to be economically viable, and he saw England as essential to the future survival of the Centre, as well as of benefit to England.

Published on: 30 August, 2024

The Scottish Home Health Department asked the DHSS when the Protein Fractionation Centre would be provided with English plasma for fractionation.

Published on: 30 August, 2024

It was reported at a DHSS meeting that the Minister of State stressed the need for cooperation between Scotland and England in manufacturing blood products.

Published on: 30 August, 2024

It was agreed at a SNBTS meeting that no start should be made on the large-scale processing of plasma from England and Wales until a plan had been agreed by transfusion directors.

Published on: 30 August, 2024

Transfusion directors agreed at an SNBTS meeting that Mr Watt could process a limited amount of plasma from BPL to establish yield and costs.

Published on: 30 August, 2024

It was agreed that Scotland should provide its own supply of fractions before undertaking work for the NBTS in England.

Published on: 30 August, 2024

John Watt, of the Scottish National Blood Transfusion Service, reported to the DHSS that a fifth of stored plasma had been processed.

Published on: 30 August, 2024

Dr Maycock wrote to the DHSS to tell them 25,000 litres of plasma per year would be available for fractionation by PFC, to begin in the autumn.

Published on: 30 August, 2024

Dr Maycock estimated BPL/PFL's contribution was 17.5 million international units per annum for England.

Published on: 30 August, 2024

SHHD said that it should be prepared for the PFC to be accepted as a pharmaceutical factory-type development.

Published on: 30 August, 2024

Within his oral evidence to the Inquiry, Dr Peter Foster explained how a fractionation centre should support a population of at least 15 million to be economically viable.

Published on: 30 August, 2024

Within a letter from John Watt to Robert Roberts, John Watt stressed that the plant was considerably underutilised and could process blood to serve a population of around 25 million.

Published on: 30 August, 2024

Within a letter from David Stevenson to A Eason a possible solution was proposed regarding the problem of securing an agreement acceptable to the workforce if asked to run a 24-hour shift system.

Published on: 30 August, 2024

A letter from Alec Parrott to Susan Maunsel stated that "even if all the difficulties in shift working at Liberton could be overcome tomorrow, it would not be regarded as sensible policy to put all our eggs in the Scottish basket as the planners appear to have originally intended."

Published on: 30 August, 2024

In 1981, a trial of shift working was conducted at Edinburgh and it was determined that the CSVM system was capable of continuous operation for periods of at least 120 hours.

Published on: 30 August, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2130
  • Page 2131
  • Page 2132
  • Page 2133
  • Current page 2134
  • Page 2135
  • Page 2136
  • Page 2137
  • Page 2138
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.